CompletedNCT01624649
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
Observational studyAges 6–15South Korea
Understand this study
Who was this study for?
Listed age limits: 6 years to 15 years.
- Listed locations
- Bucheon-Si Gyeonggi-Do and 8 more locationsSee all locations and recruitment
Study information
Study start dateFebruary 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 289
- Sponsor
- Janssen Korea, Ltd., Korea
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- South Korea
- Age range
- From 6 Years to 15 Years
- Official registry ID
- NCT01624649
- Official title
Show the full official title
Prospective Follow-Up Observational Study to Examine the Progression of ADHD Drug Treatment and to Analyze Associated Factors
Get this study by email
Recruitment & locations
CompletedBucheon-Si Gyeonggi-Do · Daegu · Gyeongsangnam-Do
6 more locations
- Jeju Special Self-Governing Province
- Jeonju
- Kyunggi-Do
- Seongnam
- Seoul
- Suwon
Questions about this study
Who is behind this study?
The study sponsor is Janssen Korea, Ltd., Korea.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate hydrochloride and Atomoxetine.
Who was this study for?
Listed age limits: 6 years to 15 years.
